Investing Profile

Asish Xavier

InvestorVC
Vice President, Venture Investments at Johnson & Johnson Innovation - JJDC, Inc
jnjinnovation.com/team/asish-...South San Francisco, California
Photo of Asish Xavier, Investor at Johnson & Johnson Innovation
Your Intro Paths to Asish Xavier

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Asish is a member of
University of Pennsylvania - The Wharton School Network
199 CONNECTIONS
The Johns Hopkins University Network
46 CONNECTIONS
Johnson & Johnson Network
17 CONNECTIONS
Johnson & Johnson Network
17 CONNECTIONS
Johnson & Johnson Network
17 CONNECTIONS

Find Asish Xavier on

cb
Current Investing Position
Johnson & Johnson Innovation Investor
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
21

Asish Xavier is on these Sector & Stage Rankings

Asish Xavier's Investments On Record (9)

CompanyStageDateRound SizeTotal Raised
SonoThera
Series ADec 2022$61M
$61M
Co-investors: Lori Hu (Vertex Ventures), Tom Willis (Illumina Ventures), Brian Halak (Domain Associates), Steven Gillis (ARCH Venture Partners)
PhaseBio Pharmaceuticals
Series CMar 2015$40M
Series BJun 2012$23M
Series BJan 2010$25M
Series UnknownOct 2007$7M
$130M
Co-investors: Justin Klein (Vensana Capital), Robert Ingram (Hatteras Venture Partners), James Barrett
Aduro BioTech
Series CJun 2014$56M
$56M
ViaCyte
Series CJul 2013$11M
Series CJul 2007$25M
Series UnknownMay 2006$20M
$140M
Co-investors: Heath Lukatch (Red Tree Venture Capital), Adam Koppel (Bain Capital Life Sciences)
Protagonist Therapeutics
Series BJun 2013$14M
$54M
Co-investors: Julie Grant (Canaan Partners)
Aquinox Pharmaceuticals
Series CApr 2013$18M
Series BJun 2010$25M
Series AJun 2007$15M
$58M
Catalyst Biosciences
Post Ipo EquityApr 2013$5M
Post Ipo EquitySep 2012$13M
Post Ipo EquityDec 2008$40M
$88M
Co-investors: Nassim Usman (Morgenthaler Ventures), Ralph (Chris) Christoffersen (Morgenthaler Ventures)
Nevro
Series CMar 2013$48M
Series BJul 2011$58M
$130M
Co-investors: Paul Klingenstein (Aberdare Ventures), Peter Bisgaard (Pivotal bioVenture Partners)

Asish Xavier's Experience

Board Observer Pipeline Therapeutics2023 - Present
Member Board of Directors SonoThera2022 - Present
Member Board Of Directors Paige2021 - Present
Member Board Of Directors Verana Health2021 - Present
Investor Legend Biotech2020 - Present
J&J Innovation - JJDC, Vice President, Venture Investments Johnson & Johnson2007 - Present
Member Board of Directors XWPharma 凯瑞康宁2019 - 2023
Member Board of Directors ESCAPE Bio2015 - 2022
Member Board of Directors ViaCyte2007 - 2022
Board Observer Datavant2020 - 2021
Member Board of Directors Cue Health Inc.2020 - 2021
Member Board of Directors Accelerator Life Science Partners2014 - 2021
Member Board of Directors Adicet Bio, Inc2019 - 2020
Member Board Of Directors Fusion Pharmaceuticals2017 - 2020
Member Board of Directors BlackThorn Therapeutics2015 - 2020
Member Board of Directors PhaseBio Pharmaceuticals, Inc.2009 - 2017
Member Board of Directors Protagonist Therapeutics2013 - 2016
Board Observer Aduro Biotech, Inc.2014 - 2015
Member Board of Directors Catalyst Biosciences2007 - 2015
Board Observer Nevro2011 - 2014
Member Board of Directors Genocea Biosciences2010 - 2014
Member Board of Directors Celladon Corporation2007 - 2014
Member Board of Directors Aquinox Pharmaceuticals, Inc.2006 - 2014
Member Board of Directors Aldeyra Therapeutics2005 - 2014
Board Observer Five Prime Therapeutics, Inc.2006 - 2013
Member Board of Directors Navitor Pharmaceuticals2009 - 2012
Principal, Venture Investments Johnson & Johnson2006 - 2007
Senior Associate, Venture Investments Johnson & Johnson2004 - 2006
Manager, Business Development BioRexis Pharmaceuticals Corporation2003 - 2004
Group Leader, R&D Message Pharmaceuticals1999 - 2001

Asish Xavier's Education

The Johns Hopkins University Postdoctoral Fellow
University of Houston Ph.D.
Indian Institute of Technology, Kanpur B.Tech.
University of Pennsylvania - The Wharton School MBA